Clinical Trial

Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer

Name: Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer — clinical trial record (NCT07714447)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study investigated the efficacy and safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-15.

Trial Details

NCT Number	NCT07714447
Lead Sponsor	Sun Yat-sen University
Conditions	CRC (Colorectal Cancer), BRAF
Enrollment	91 participants
Start Date	2026-11-30
Primary Completion	2029-02-01 (estimated)
Study Completion	2029-02-26 (estimated)
Updated on ClinicalTrials.gov	2026-07-21